Details for Patent: 9,789,078
✉ Email this page to a colleague
Which drugs does patent 9,789,078 protect, and when does it expire?
Patent 9,789,078 protects PICATO and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 9,789,078
| Title: | Method of topically treating actinic keratosis with ingenol mebutate cycle therapy |
| Abstract: | The present invention relates to cyclic or repeated use of the ingenol mebutate for topical treatment of actinic keratosis lesions. Generally speaking, the present invention comprises a first ingenol mebutate treatment cycle and a second ingenol mebutate treatment cycle, wherein the first treatment cycle topically treats a treatment area with a topical gel formulated with ingenol mebutate at a selected dosage strength for a specified treatment regimen, and the second ingenol mebutate treatment cycle comprises topically re-treating the treatment area with the same topical ingenol mebutate gel for the same specified treatment regimen, if following the first treatment cycle, the treatment area failed to clear or failed to remain clear of AK lesions. The present invention further relates to spot or individual lesion therapy in the treatment area following the topical bi-cyclic therapy with ingenol mebutate. |
| Inventor(s): | Norrelund; Kirsten (Ballerp, DK) |
| Assignee: | LEO Laboratories Limited (Dublin, IE) |
| Application Number: | 14/401,492 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; |
Drugs Protected by US Patent 9,789,078
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leo Labs | PICATO | ingenol mebutate | GEL;TOPICAL | 202833-001 | Jan 23, 2012 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TOPICAL TREATMENT OF ACTINIC KERATOSIS OF THE FACE OR SCALP USING MORE THAN ONE TREATMENT COURSE OF INGENOL MEBUTATE | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,789,078
| PCT Information | |||
| PCT Filed | May 15, 2013 | PCT Application Number: | PCT/EP2013/060024 |
| PCT Publication Date: | November 21, 2013 | PCT Publication Number: | WO2013/171258 |
International Family Members for US Patent 9,789,078
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2849742 | ⤷ Try a Trial | |||
| World Intellectual Property Organization (WIPO) | 2013171258 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
